Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-38 Cr₹389 Cr₹19 Cr₹255 Cr₹14 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS is ₹-38 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-38 Cr
Mar2024₹389 Cr
Mar2023₹19 Cr
Mar2022₹255 Cr
Mar2021₹14 Cr

How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-38 Cr
Negative
Mar2024 ₹389 Cr
1,902.17
Mar2023 ₹19 Cr
-92.37
Mar2022 ₹255 Cr
1,695.19
Mar2021 ₹14 Cr -

Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹58,301.1 Cr 2.9% 5.1% 25.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,929.0 Cr 0.7% -4.2% -8.7% Stock Analytics
DIVIS LABORATORIES ₹169,644.0 Cr 0% -1% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹131,481.0 Cr 2.4% 4.5% 14.5% Stock Analytics
CIPLA ₹122,050.0 Cr 1.1% 0.2% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,784.0 Cr -1% -2% -9.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.9%

5.1%

25.9%

SENSEX

0.9%

0.7%

9.6%


You may also like the below Video Courses